Steve Forte's most recent trade in Repare Therapeutics Inc was a trade of 500,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on April 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 500,000 | 500,000 | - | - | Employee Stock Option (right to buy) | |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 12 Mar 2025 | 6,884 | 54,786 | - | 1.1 | 7,848 | Common Shares |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 85,000 | 85,000 | - | - | Employee Stock Option (right to buy) | |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 14,000 | 61,670 | - | 0 | Common Shares | |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.62 per share. | 28 Mar 2024 | 825 | 45,564 | - | 4.6 | 3,812 | Common Shares |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.61 per share. | 28 Mar 2024 | 789 | 44,775 | - | 4.6 | 3,637 | Common Shares |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.60 per share. | 25 Mar 2024 | 825 | 43,037 | - | 4.6 | 3,795 | Common Shares |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.79 per share. | 25 Mar 2024 | 825 | 43,862 | - | 4.8 | 3,952 | Common Shares |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.62 per share. | 25 Mar 2024 | 825 | 42,212 | - | 4.6 | 3,812 | Common Shares |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (right to buy) | |
| Repare Therapeutics Inc | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 14,000 | 44,687 | - | 0 | Common Shares | |
| Repare Therapeutics Inc | Steve Forte | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 111,050 | 111,050 | - | - | Employee Stock Option (right to buy) | |
| Repare Therapeutics Inc | Steve Forte | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 24,530 | 30,687 | - | 0 | Common Shares | |
| Repare Therapeutics Inc | Steve Forte | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Repare Therapeutics Inc | Steve Forte | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 71,000 | 71,000 | - | - | Employee Stock Option (right to buy) |